Barker D F, Pruchno C J, Jiang X, Atkin C L, Stone E M, Denison J C, Fain P R, Gregory M C
Department of Physiology, University of Utah Health Sciences Center, Salt Lake City, USA.
Am J Hum Genet. 1996 Jun;58(6):1157-65.
Mutations in the COL4A5 gene, located at Xq22, cause Alport syndrome (AS), a nephritis characterized by progressive deterioration of the glomerular basement membrane and usually associated with progressive hearing loss. We have identified a novel mutation, L1649R, present in 9 of 121 independently ascertained families. Affected males shared the same haplotype of eight polymorphic markers tightly linked to COL4A5, indicating common ancestry. Genealogical studies place the birth of this ancestor >200 years ago. The L1649R mutation is a relatively common cause of Alport syndrome in the western United States, in part because of the rapid growth and migratory expansion of mid-nineteenth-century pioneer populations carrying the gene. L1649R affects a highly conserved residue in the NC1 domain, which is involved in key inter- and intramolecular interactions, but results in a relatively mild disease phenotype. Renal failure in an L1649R male typically occurs in the 4th or 5th decade and precedes the onset of significant hearing loss by approximately 10 years.
位于Xq22的COL4A5基因突变会导致奥尔波特综合征(AS),这是一种以肾小球基底膜进行性恶化为特征的肾炎,通常伴有进行性听力丧失。我们发现了一个新的突变L1649R,在121个独立确定的家族中有9个家族存在该突变。受影响的男性共享与COL4A5紧密连锁的8个多态性标记的相同单倍型,表明有共同的祖先。系谱研究表明这位祖先生活在200多年前。L1649R突变是美国西部奥尔波特综合征相对常见的病因,部分原因是携带该基因的19世纪中叶先驱人群的快速增长和迁移扩张。L1649R影响NC1结构域中一个高度保守的残基,该残基参与关键的分子间和分子内相互作用,但导致的疾病表型相对较轻。L1649R男性患者的肾衰竭通常发生在第四或第五个十年,且比明显听力丧失的发作提前约10年。